MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

CV — CapsoVision, Inc. Common Stock

Nasdaq

CapsoVision, Inc. Common Stock

CompareBack to Screener
$6.17
-0.15(-2.37%)
O
6.35
H
6.40
L
6.12
V
128.72K
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About CV

CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.

IndustryELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
SectorNot available
IPO DateJul 2, 2025
Employees99
Stock ExchangeNasdaq
Ticker SymbolCV

Key Financial Statistics

Market Cap$328.31M
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$4.38 - $15.37
52-Week Avg Volume226.1K
VWAP$6.21
Transactions2,248
Total Recorded Bars316 days